Table 4:
KEGG Pathway | Cyp2b-null ND vs WT ND | WT HFD vs WT ND | Cyp2b-null HFD vs WT HFD |
---|---|---|---|
PI3K-Akt signaling | 11 | 12 | 2 |
Protein processing in endoplasmic reticulum | 10 | 1 | 0 |
Retinol metabolism | 7 | 13 | 1 |
MAPK signaling | 7 | 12 | 1 |
Glycerophospholipid metabolism | 7 | 1 | 1 |
Hepatocellular carcinoma | 6 | 11 | 1 |
Drug metabolism | 6 | 9 | 0 |
Thyroid hormone signaling | 6 | 5 | 1 |
Apoptosis | 6 | 1 | 0 |
PUFA metabolism | 5 | 10 | 3 |
Insulin signaling/resistance | 5 | 3 | 2 |
Circadian rhythm | 4 | 2 | 3 |
NAFLD | 4 | 2 | 0 |
Phospholipase D signaling | 4 | 0 | 0 |
Glutathione metabolism | 2 | 12 | 0 |
Cholesterol metabolism | 1 | 4 | 2 |
Total Perturbations | 646 | 620 | 75 |